Pharmalink AB Receives Patent for Nefecon(R) Principle

STOCKHOLM - - Japanese Grant Supports Asian Partnering Programme Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, “Methods and means for treating glomerulonephritis” for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD). Counterparts of the patent have been issued for [...]

Read this article...